A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02634307 |
Recruitment Status :
Active, not recruiting
First Posted : December 18, 2015
Last Update Posted : September 14, 2020
|
Sponsor:
Biogen
Collaborator:
Alkermes, Inc.
Information provided by (Responsible Party):
Biogen
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | May 17, 2021 |
Estimated Study Completion Date : | July 31, 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):